FDA approves Lonsurf for gastric cancer

Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) said FDA approved Lonsurf trifluridine/tipiracil for adult patients with

Read the full 153 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE